Bill

BILL • US HOUSE

HR 7601

No Immunity for Glyphosate Act

119th Congress
Introduced by Lauren Boebert, Joe Courtney, Ro Khanna and 4 other co-sponsors

HR 7601 removes legal immunity protections for glyphosate manufacturers, allowing lawsuits by people claiming the herbicide caused cancer. The bill aims to hold companies accoun...

Introduced in House
0
0
Bill Summary • HR 7601

Legislative bill overview

HR 7601, the No Immunity for Glyphosate Act, would restrict or eliminate legal immunity protections for glyphosate manufacturers and sellers in civil litigation. The bill directly targets legal defenses that currently shield companies producing glyphosate (the active ingredient in Roundup) from liability claims. Specific legislative language would need to be reviewed to determine whether it eliminates immunity entirely, modifies evidentiary standards, or creates new liability categories.

Why is this important

Glyphosate has been the subject of significant litigation, with plaintiffs claiming exposure causes non-Hodgkin's lymphoma and other health conditions. Current legal frameworks provide certain protections to manufacturers. This bill addresses a core tension between product liability law and public health concerns—determining who bears financial responsibility when products cause alleged harm. The outcome affects both litigation access for injured parties and the regulatory and commercial environment for agricultural chemical manufacturers.

Potential points of contention

PLAINTIFFS' PERSPECTIVE: Current immunity protections prevent legitimate injury claims from reaching juries; removing them provides accountability and access to justice for harmed individuals.

MANUFACTURERS' PERSPECTIVE: Eliminating immunity creates unlimited liability exposure, discourages innovation in agricultural products, and allows litigation despite regulatory agency determinations of safety (EPA has consistently maintained glyphosate is safe at approved levels).

REGULATORY AUTHORITY CONFLICT: The bill potentially circumvents EPA's authority by allowing courts to second-guess federal safety determinations through civil litigation rather than regulatory channels.

INSURANCE AND MARKET IMPACTS: Manufacturers may face unprecedented claims volumes and costs, potentially affecting product pricing, availability, and company viability.

PRECEDENT CONCERNS: The approach could extend to other EPA-approved products, fundamentally altering product liability law.

Hi! I'm your AI assistant for HR 7601. I can help you understand its provisions, impacts, and answer any questions.

Key Provisions Impacts Timeline
Sign in to chat